Kidney dysfunction is particularly important in systemic organ injuries caused by aging. Metabolomics are utilized in this study to explore the mechanism of kidney dysfunction during aging by the identification of metabolites and the characterization of metabolic pathways. We analyzed the serum biochemistry and kidney histopathology of male Kunming mice aged 3 months and 24 months and found that the aged mice had inflammatory lesions, aggravated fibrosis, and functional impairment. A high-resolution untargeted metabolomics analysis revealed that the endogenous metabolites in the kidneys and urine of the mice were significantly changed by 25 and 20 metabolites, respectively. A pathway analysis of these differential metabolites revealed six key signaling pathways, namely, D-glutamine and D-glutamate metabolism, purine metabolism, the citrate cycle [tricarboxylic acid (TCA) cycle], histidine metabolism, pyruvate metabolism, and glyoxylate and dicarboxylate metabolism. These pathways are involved in amino acid metabolism, carbohydrate metabolism, and nucleotide metabolism, and these can lead to immune regulation, inflammatory responses, oxidative stress damage, cellular dysfunction, and bioenergy disorders, and they are closely associated with aging and kidney insufficiency. We also screened nine types of sensitive metabolites in the urine as potential biomarkers of kidney dysfunction during the aging process to confirm their therapeutic targets in senior-induced kidney dysfunction and to improve the level of risk assessment for senile kidney injury.
Dysregulation of long noncoding RNA (lncRNA) expression is related to aging and age-associated neurodegenerative diseases, and the lncRNA expression profile in the aging hippocampus is not well characterized. In the present investigation, the changed mRNAs and lncRNAs were confirmed via deep RNA sequencing. GO and KEGG pathway analyses were conducted to investigate the principal roles of the clearly dysregulated mRNAs and lncRNAs. Subsequently, through the prediction of miRNAs via which mRNAs and lncRNAs bind together, a competitive endogenous RNA network was constructed. A total of 447 lncRNAs and 182 mRNAs were upregulated, and 385 lncRNAs and 144 mRNAs were downregulated. Real-time reverse transcription-polymerase chain reaction validated the reliability of mRNA and lncRNA sequencing. KEGG pathway and GO analyses revealed that differentially expressed (DE) mRNAs were associated with cell adhesion molecules (CAMs), the p53 signaling pathway (SP), phagosomes, PPAR SP and ECM—receptor interactions. KEGG pathway and GO analyses showed that the target genes of the DE lncRNAs were related to cellular senescence, the p53 signaling pathway, leukocyte transendothelial migration and tyrosine metabolism. Coexpression analyses showed that 561 DE lncRNAs were associated with DE mRNAs. A total of 58 lncRNA–miRNA–mRNA target pairs were confirmed in this lncRNA‒miRNA‒mRNA network, comprising 10 mRNAs, 13 miRNAs and 38 lncRNAs. We found specific lncRNAs and mRNAs in the hippocampus of natural aging model rats, as well as abnormal regulatory ceRNA networks. Our outcomes help explain the pathogenesis of brain aging and provide direction for further research.
Kidney fibrosis is a central pathological feature driving progressive functional decline in chronic kidney disease (CKD); however, the molecular and epigenetic mechanisms linking kidney fibrosis to aging remain incompletely understood. In this study, we employed a natural aging mouse model and integrated transcriptomic and DNA methylation analyses to delineate age-associated kidney degenerative features and to identify key genes involved in this process. Our results showed that aging kidneys exhibited pronounced interstitial fibrosis and tubular atrophy, accompanied by increased expression of senescence markers, senescence-associated secretory phenotype (SASP) factors, and kidney injury molecule-1 (KIM-1), indicating persistent kidney injury during aging. Reduced representation bisulfite sequencing (RRBS) revealed a global, age-dependent increase in DNA methylation levels. Integrative methylome-transcriptome analyses identified fibroblast growth factor receptor 2 (FGFR2) as a prominent target of age-associated hypermethylation. Multilevel validation using RT-qPCR, Western blotting, immunofluorescence co-localization, and pyrosequencing consistently confirmed that FGFR2 expression was significantly reduced in aging kidney tissue, particularly in kidney tubular regions. Functional studies demonstrated that pharmacological inhibition of FGFR2 in vitro accelerated cellular senescence and upregulated fibrosis-related markers, supporting a causal role for FGFR2 loss in promoting kidney aging. Furthermore, reduced FGFR2 expression was accompanied by decreased co-localization with fibroblast growth factor 23 (FGF23) in aging kidneys, suggesting potential impairment of the FGF23/FGFR2 signaling axis. Collectively, these findings suggest that epigenetic silencing of FGFR2 contributes to kidney senescence and fibrotic remodeling during kidney aging and highlight FGFR2 as a potential therapeutic target for mitigating age-related kidney decline.